Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial

BACKGROUND Inflammatory bowel diseases are managed by different methods, which may not be well tolerated because of their side effects. Recently, pro-prebiotics are considered as a supplementary treatment in gastrointestinal diseases. In this study, the effect of Lactocare® (ZistTakhmir Company) was...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Middle East J Dig Dis
Egile Nagusiak: Amiriani, Taghi, Rajabli, Niloofar, Faghani, Maryam, Besharat, Sima, Roshandel, Gholamreza, Akhavan Tabib, Atefeh, Joshaghani, Hamidreza
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Iranian Association of Gastroerterology and Hepatology 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7023645/
https://ncbi.nlm.nih.gov/pubmed/32082518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/mejdd.2020.160
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak